Question 1

What does Generex Biotechnology do?

Accepted Answer

Generex Biotechnology develops and commercializes drug delivery systems and technologies for metabolic and immunological diseases.

Question 2

In what sectors does Generex Biotechnology operate?

Accepted Answer

Generex Biotechnology operates in Biopharma, Biotechnology, Medical Device, Pharmaceutical.

Question 3

How many companies has Generex Biotechnology acquired?

Accepted Answer

Generex Biotechnology has made 5 acquisitions between 2017-2019, with a total disclosed deal value of $240.0M.

Question 4

How many acquisitions does Generex Biotechnology make in a year?

Accepted Answer

Over the last 5 years, Generex Biotechnology has made about 1 acquisitions per year.

Question 5

What companies are owned by Generex Biotechnology?

Accepted Answer

Companies acquired by Generex Biotechnology include Altucell, Medisource Partners, Regentys, Olaregen Therapeutix, Emmaus Medical.

Question 6

What are Generex Biotechnology's major acquisitions?

Accepted Answer

Generex Biotechnology's largest acquisitions include Emmaus Medical ($225.0M, 2017), Regentys ($15.0M, 2019).

Question 7

What is Generex Biotechnology's largest acquisition?

Accepted Answer

Generex Biotechnology's largest disclosed acquisition is Emmaus Medical for $225.0M (2017).

Question 8

What was Generex Biotechnology's first acquisition?

Accepted Answer

Generex Biotechnology's first recorded acquisition was Emmaus Medical in 2017 for $225.0M.

Question 9

What was Generex Biotechnology's most recent acquisition?

Accepted Answer

Generex Biotechnology's most recent acquisition is Altucell, announced November 2019.

Question 10

What is the average deal size for Generex Biotechnology acquisitions?

Accepted Answer

The average disclosed deal size for Generex Biotechnology acquisitions is $120.0M.

Question 11

What is the median deal size for Generex Biotechnology acquisitions?

Accepted Answer

The median disclosed deal size for Generex Biotechnology acquisitions is $120.0M. The median is often lower than the average because a few very large deals pull the average up.

Question 12

How much has Generex Biotechnology spent on acquisitions?

Accepted Answer

Generex Biotechnology has spent at least $240.0M across its disclosed acquisitions (of 5 total deals; some prices are undisclosed).

Question 13

Which sector has Generex Biotechnology spent the most on?

Accepted Answer

Generex Biotechnology has committed the most disclosed capital to Health Care companies — about $240.0M across its deals in that sector.

Question 14

What sectors does Generex Biotechnology usually acquire in?

Accepted Answer

Generex Biotechnology most frequently acquires companies in Biotechnology, Medical Device, Health Care.

Question 15

In which sector has Generex Biotechnology made the most acquisitions?

Accepted Answer

Generex Biotechnology has made the most acquisitions in the Biotechnology sector.

Question 16

In which year did Generex Biotechnology make the most acquisitions?

Accepted Answer

Generex Biotechnology made the most acquisitions in 2019, with 3 deals.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Generex Biotechnology

Company Details

Funding & Financials

Web Traffic

Company Info

Acquisitions by Generex Biotechnology

Key People at Generex Biotechnology

Explore 200,000+ acquisitions — free

Recent News related to Generex Biotechnology

FAQs about Generex Biotechnology

People who checked this page also checked these